When.com Web Search

  1. Ads

    related to: her2 positive breast cancer survivors

Search results

  1. Results From The WOW.Com Content Network
  2. HER2 - Wikipedia

    en.wikipedia.org/wiki/HER2

    HER2 testing is performed on breast biopsy of breast cancer patients to assess prognosis and to determine suitability for trastuzumab therapy. It is important that trastuzumab is restricted to HER2-positive individuals as it is expensive and has been associated with cardiac toxicity. [41]

  3. Nancy Lin - Wikipedia

    en.wikipedia.org/wiki/Nancy_Lin

    After completing her medical training, Lin focused on the diagnosis, treatment and outcomes of people with breast cancer. [4] In particular, she worked on HER2 positive breast cancer and breast cancer patients with brain metastasis. [5] [6] [7] Lin has developed novel pharmaceuticals for patients whose breast cancer has spread to the brain.

  4. Breast cancer management - Wikipedia

    en.wikipedia.org/wiki/Breast_cancer_management

    Staging breast cancer is the initial step to help physicians determine the most appropriate course of treatment. As of 2016, guidelines incorporated biologic factors, such as tumor grade, cellular proliferation rate, estrogen and progesterone receptor expression, human epidermal growth factor 2 (HER2) expression, and gene expression profiling into the staging system.

  5. What is stage I triple-positive breast cancer? - AOL

    www.aol.com/lifestyle/office-star-jenna-fischer...

    The Office alum shared on Oct. 8 that she was diagnosed with stage I triple-positive breast cancer on Dec. 1, 2023, and over the past few months, underwent a lumpectomy, chemotherapy and radiation ...

  6. Olivia Munn shares detailed timeline of breast cancer ...

    www.aol.com/news/olivia-munn-43-reveals-she...

    HER2 is the protein that helps breast cancer cells grow, per the American Cancer Society. When it's negative, that means the cancer isn't likely to respond to drugs that target HER2.

  7. Xavier Pivot - Wikipedia

    en.wikipedia.org/wiki/Xavier_Pivot

    Pivot's study represented the largest French academic study in breast cancer, carried out with 3,484 patients with HER2-overexpressing breast cancer. Pivot was also involved in the late 2010s in the creation of trastuzumab biosimilars, the aim of which is to offer identical efficacy at a lower cost.

  1. Ads

    related to: her2 positive breast cancer survivors